Arkansas accuses pharma companies of plot to undermine federal drug discount program

Arkansas Attorney General Tim Griffin sued pharmaceutical companies including Johnson & Johnson, Eli Lilly, Pfizer, and AstraZeneca, alleging they conspired to block healthcare providers from accessing discounted drugs under the 340B federal program. The companies are accused of imposing restrictive requirements to limit the use of contract pharmacies, which covered entities rely on to serve underserved communities.